← USPTO Patent Grants

Cells for enhanced production of adeno-associated virus

Grant US12577539B2 Kind: B2 Mar 17, 2026

Assignee

The Regents of the University of California

Inventors

David V. Schaffer, Christopher Barnes, David Stephen Ojala

Abstract

The present disclosure provides an in vitro mammalian cell that is genetically modified to provide for enhanced production of adeno-associated virus (AAV) virions. The mammalian cells can be used to produce AAV virions, e.g., recombinant AAV virions that include a heterologous nucleic acid encoding a gene product; the present disclosure thus provides methods for producing an AAV virion, which may be a recombinant AAV virion.

CPC Classifications

C12N 7/00 C12N 15/1058 C12N 15/11 C12N 15/63 C12N 15/85 C12N 15/86 C12N 2310/20 C12N 2310/02 C12N 2750/14152 C12N 2800/107

Filing Date

2020-04-22

Application No.

17605387

Claims

10